| Pharmaceutical Information |
| Drug Name |
Ropivacaine |
| Drug ID |
BADD_D02416 |
| Description |
Ropivacaine is an aminoamide local anaesthetic drug commonly marketed by AstraZeneca under the trade name Naropin. It is present as a racemic mixture of the enantiomers containing equal proportions of the “S” and “R” forms. The marketed form contains the single S-enantiomer as the active ingredient. |
| Indications and Usage |
Used in obstetric anesthesia and regional anesthesia for surgery. |
| Marketing Status |
approved |
| ATC Code |
N01BB09 |
| DrugBank ID |
DB00296
|
| KEGG ID |
D08490
|
| MeSH ID |
D000077212
|
| PubChem ID |
175805
|
| TTD Drug ID |
D09RHQ
|
| NDC Product Code |
76339-126; 29902-0022 |
| UNII |
7IO5LYA57N
|
| Synonyms |
Ropivacaine | 1-Propyl-2',6'-pipecoloxylidide | 1 Propyl 2',6' pipecoloxylidide | Naropin | Ropivacaine Monohydrochloride | Ropivacaine Hydrochloride | AL 381 | AL-381 | AL381 | Naropeine | LEA 103 | LEA-103 | LEA103 | Ropivacaine Monohydrochloride, (S)-isomer |
|
| Chemical Information |
| Molecular Formula |
C17H26N2O |
| CAS Registry Number |
84057-95-4 |
| SMILES |
CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
